ArticleEJHaem2025

Impact of Reduction in Myeloid-derived Suppressor Cells by Wilms' Tumor 1-targeted Dendritic Cell Vaccines on Clinical Outcomes in Acute Leukemia Patients.

Masahiro Ogasawara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.